Skip to content
Search
Register / Sign in
MSCI China
|
MSCI China Small-Cap
|
Hang Seng Index
|
Hang Seng China Enterprise
Categories
IPO
Ecommerce
Finance
Social Media/Entertainment
Consumer
Education
Healthcare/biotech
New Energy
AI/Infrastructure/Resources
Property
China ESG Focus
Fast News
Expert Corner
Audio/Video
IPO
About
Who We Are
Our Writers
Partner with us
Contact Us
Join us
Eng
简中
繁中
Menu
Categories
IPO
Ecommerce
Finance
Social Media/Entertainment
Consumer
Education
Healthcare/biotech
New Energy
AI/Infrastructure/Resources
Property
China ESG Focus
Fast News
Expert Corner
Audio/Video
IPO
About
Who We Are
Our Writers
Partner with us
Contact Us
Join us
Stories About 1530.HK
The global leap: Chinese biopharma, athletic brands dip toes in global waters
2026-05-20
Mega licensing deal lifts 3SBio profits but core sales slip
2026-04-09
3SBio gears up for drugs battle with $400 million equity move
2025-12-11
3SBio hits the big time with $6 billion cancer drug deal
2025-05-29
Recent Articles
June 23, 2026
Momenta IPO cleared by Hong Kong Stock Exchange, CSRC
June 23, 2026
SiliconFlow’s AI ‘token factory’ dream gets $300 million vote of confidence
June 23, 2026
Zhida to raise $26 million through share placement at 12% discount
2650.HK
June 23, 2026
HJ Science tumbles in Hong Kong trading debut
6132.HK
June 23, 2026
Trunk Technology drives ahead in search of profits
June 22, 2026
Luxshare gets CSRC nod for Hong Kong IPO
002475.SHE
June 22, 2026
Laifual seeks $147 million in Hong Kong IPO
3952.HK
RELATED ARTICLES
No related posts.
Discover hidden China stock gems in our weekly newsletter
Email Address *
Newsletter Type
English Version
Chinese Version
Sign-up
Follow us
Facebook
Twitter
Linkedin
Weixin
Weibo
Youtube
Subscribe to Our Free eNewsletter
Subscribe
Check out our content with some of our syndication partners
